The Efficacy and Safety of Radiofrequency Microneedling for Melasma: A Systematic Review and Qualitative Evidence Synthesis
Authors:
Open Access
- 14 January 2026
- journal article
- review article
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag075
Abstract
Melasma is a chronic, relapsing hyperpigmentation disorder that is difficult to treat, particularly in Fitzpatrick skin types III-V, where energy-based devices frequently induce postinflammatory hyperpigmentation (PIH). Radiofrequency microneedling (RFMN) has emerged as a promising alternative because it targets dermal pathology while minimizing epidermal injury. Systematically evaluate the efficacy, safety, and mechanistic rationale of RFMN for melasma. A PRISMA 2020 compliant search of PubMed, Embase, Cochrane CENTRAL, and LILACS (2014-2025) identified clinical studies evaluating RFMN alone or in combination therapies. Risk of bias was assessed using Joanna Briggs Institute tools. Owing to clinical and methodological heterogeneity, a qualitative synthesis was performed. Across 12 included studies, RFMN consistently improved Melasma Area and Severity Index (MASI) or modified MASI scores and melanin indices, with effects maintained up to 6 months. Histological evidence demonstrated reductions in dermal senescence markers and partial restoration of basement-membrane integrity. RFMN also showed a favorable safety profile, with a low incidence of PIH in darker phototypes. Combination treatment, particularly with low-fluence Q-switched Nd:YAG laser produced greater pigment reduction than monotherapy. RFMN is an effective and safe modality for melasma, offering advantages over pigment-directed lasers by addressing dermal mechanisms and limiting PIH risk. It may serve as a first-line energy-based therapy. Level of Evidence:3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.Keywords
Funding Information
- Jeisys Med Inc., Seoul, Republic of South Korea
This publication has 17 references indexed in Scilit:
- Melasma management: Unveiling recent breakthroughs through literature analysisHealth Sciences Review, 2025
- Review of Applications of Microneedling in MelasmaJournal of Cosmetic Dermatology, 2024
- Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In‐Office and Home‐Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle‐Control, Randomized Control TrialJournal of Cosmetic Dermatology, 2024
- Efficacy of Microneedle as an Assisted Therapy for Melasma: A Meta-analysis and Systematic Review of Randomized Controlled TrialsAesthetic Plastic Surgery, 2024
- Targeting the dermis for melasma maintenance treatmentScientific Reports, 2024
- Can Microneedle Fractional Radiofrequency System Treatment Impair the Skin Barrier Function in Chinese Patients? A Prospective Clinical TrialDermatology and Therapy, 2022
- Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot StudyDermatology and Therapy, 2022
- Therapeutic Effects of New Pulsed-Type Microneedling Radiofrequency for Refractory Facial Pigmentary DisordersDermatologic Surgery, 2022
- Senescent fibroblasts in melasma pathophysiologyExperimental Dermatology, 2018
- Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequencyJournal of Dermatological Treatment, 2018